NASDAQ · FTXH
First Trust Nasdaq Pharmaceuticals ETF
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
Loading market information…
AMEX · RAYJ · USD
Stock price, dividends
Quote as of Jul 30, 2026, 07:26 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Rayliant SMDAM Japan Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 10.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Rayliant SMDAM Japan Equity ETF’s forward annual dividend is $2.45 per share, paid semi-annual. The forward yield is 6.53% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
Under typical market conditions, the Rayliant SMDAM Japan Equity ETF dedicates a minimum of 80% of its total investable capital—encompassing both its net assets and any funds acquired through borrowing—to equity securities issued by companies based in Japan. Specifically, its primary holdings within these equity investments consist of common stock and preferred stock. Notably, this fund is categorized as non-diversified.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$47.86-$0.25 (-0.52%)
Leuthold Select Industries ETF’s quoted price sits in the upper half of its reported 52-week range, 6.8% below the high.
$36.55-$0.15 (-0.41%)
DoubleLine Fortune 500 Equal Weight ETF’s quoted price sits in the upper half of its reported 52-week range, 7.97% below the high.
$77.25-$2.99 (-3.73%)
Putnam Emerging Markets Ex-China ETF’s quoted price sits in the lower half of its reported 52-week range, 18.85% below the high.
$32.24-$0.56 (-1.71%)
AllianzIM U.S. Equity 6 Month Buffer10 May/Nov ETF’s quoted price sits in the upper half of its reported 52-week range, 1.92% below the high.
$21.53-$0.28 (-1.26%)
Adaptive Tactical Rotation ETF’s quoted price sits in the upper half of its reported 52-week range, 8.21% below the high.
$35.26-$0.68 (-1.89%)
Infrastructure Capital Small Cap Income ETF’s quoted price sits in the lower half of its reported 52-week range, 12.38% below the high.
$55.45+$0.37 (+0.67%)
First Trust Emerging Markets Equity Select ETF’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
